apge: the income statement

MyFinsight

Apogee Therapeutics, Inc. (APGE)

For the quarter ending 2025-06-30, APGE made $7,141K in revenue. -$66,096K in net income. Net profit margin of -925.58%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

	2025-06-30
Provision for income taxes	72
Interest income, net	7,141
Total other income, net	7,141
Research and development	55,703
General and administrative	17,462
Total operating expenses	73,165
Loss from operations	-73,165
Net loss before taxes	-66,024
Net loss after taxes	-66,096

Earnings per share, basic	-1.13
Earnings per share, diluted	-1.13
Weighted average number of shares outstanding, basic	58,428,344
Weighted average number of shares outstanding, diluted	58,428,344

Unit: Thousand (K) dollars (except for numbers of shares and EPS)